CLOSE X

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE1298.7520.3 (+1.59 %)
PREV CLOSE ( ) 1278.45
OPEN PRICE ( ) 1278.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3521
TODAY'S LOW / HIGH ( )1270.20 1304.20
52 WK LOW / HIGH ( )810.1 1593
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 25-01 2007
Management Info
Amit Indubhushan Bakshi - Chairman Amit Indubhushan Bakshi - Managing Director
Registered Office

Address Shivarth Ambit, Plot No. 142/2,Ramdas Road, Off S B R,Near Swati Bungalows, Bodakdev,
Ahmedabad,
Gujarat-380054

Phone 079 30451000 / 1001

Email eris@erislifesciences.com

Website www.eris.co.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
04Dec Eris Lifesciences informs about invest
In accordance with the applicable requirements and regulations of the Se..
15Oct Eris Lifesciences acquires 100% stake
Eris Lifesciences has completed the acquisition of 100% stake in Chemman..
13Sep Eris Lifesciences informs about analys
In accordance with the applicable requirements and regulations of the Se..
26Aug Eris Lifesciences informs about disclo
Eris Lifesciences has informed that it enclosed disclosure under Regulat..
26Aug Eris Lifesciences informs about disclo
Eris Lifesciences has informed that it enclosed disclosure under Regulat..
Financials
Rs. in Millions
QTR Sep 24 ANNUAL 24
Net Profit2812997.12
Gross Profit 460.2 3288.33
Operating Profit 1484.44886.42
Net Sales 4365.614867.06
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 13417.20 (0.96%)
M.Cap ( in Cr)17214.12
Procter&Gamble Healt (BSE)
 5424.60 (2.04%)
M.Cap ( in Cr)9004.50
Ajanta Pharma (BSE)
 2879.50 (2.30%)
M.Cap ( in Cr)35968.44
Alivus Life Sciences (BSE)
 1062.45 (4.08%)
M.Cap ( in Cr)13018.50
Medplus Health Servi (BSE)
 797.25 (2.81%)
M.Cap ( in Cr)9542.59
Shareholding Pattern
PROMOTERS 54.87%
NON-INSTITUTION 18.47%
MUTUAL FUNDS/UTI 17.03%
FI/BANKS/INSURANCE 0.92%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data December 2024 Broking Complaints Data December 2024 PMS Complaints Data December 2024 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS|KYC |IPO |CLIENT BANK A/C

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.